Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

518
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
518
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

567
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
567
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

1.0K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.0K
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

782
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
782
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

440
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
440
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

368
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
368

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN).

Circulation. Heart failure·2026
Same author

Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction.

JAMA cardiology·2026
Same author

Navigating Complexity: Contemporary Patient Selection and Advanced Therapies in Heart Failure.

Heart failure clinics·2026
Same author

After the Code: The Space That Follows.

Journal of the American College of Cardiology·2026
Same author

First use of imlifidase desensitization in a highly sensitized heart and liver transplant candidate: A case report.

Human immunology·2025
Same author

Evaluating feasibility, health impact, and participant feedback of the Utah South Asian Cardiovascular Health Initiative (U-SACHI): A community-based screening and intervention program.

Journal of cardiology·2025

Related Experiment Video

Updated: Mar 29, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.6K

Approach to Mitral Regurgitation in Advanced Heart Failure.

Long-Co Nguyen1, Kevin S Shah2

  • 1Division of Cardiovascular Medicine, University of California Irvine, Irvine, CA, USA.

Heart Failure Clinics
|March 27, 2026
PubMed
Summary

Secondary mitral regurgitation (MR), a heart failure complication from ventricular remodeling, may benefit from transcatheter edge-to-edge repair in select patients. Careful patient selection is crucial, as intervention is not beneficial for proportionate MR.

Keywords:
Heart failureMitral regurgitationTranscatheter edge-to-edge repair

More Related Videos

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

7.7K
High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart
11:50

High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart

Published on: July 9, 2010

24.9K

Related Experiment Videos

Last Updated: Mar 29, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.6K
An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

7.7K
High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart
11:50

High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart

Published on: July 9, 2010

24.9K

Area of Science:

  • Cardiology
  • Heart Failure Management
  • Interventional Cardiology

Background:

  • Secondary mitral regurgitation (MR) is a frequent and significant complication in heart failure patients.
  • It arises from adverse ventricular remodeling, not primary valve disease.

Purpose of the Study:

  • To summarize the role of transcatheter edge-to-edge repair (TEER) for secondary MR in heart failure.
  • To emphasize the importance of patient selection based on MR severity and ventricular dimensions.

Main Methods:

  • Review of clinical trial data, focusing on the COAPT trial.
  • Analysis of patient phenotyping for optimal candidate selection for TEER.

Main Results:

  • Optimized medical therapy is the cornerstone for heart failure management.
  • Transcatheter edge-to-edge repair may benefit carefully selected patients with disproportionately severe MR.
  • Intervention showed no benefit in patients with proportionate MR relative to ventricular dilatation.

Conclusions:

  • Careful phenotyping is essential to identify heart failure patients who may benefit from TEER for secondary MR.
  • TEER is a valuable option for selected individuals, but not universally indicated in all secondary MR cases.